| Date | Form | Description | Docs | XBRL | Pages |
| 09/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
27 |
| 09/11/12 | 8-K | Current report filing |
|
8 | |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/10/12 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
28 | |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 8-K | Current report filing |
|
8 | |
| 08/30/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/27/12 | 8-K | Current report filing |
|
24 | |
| 06/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
46 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...